BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38733974)

  • 1. Achieving Effective Probiotic Therapy in Bacterial Vaginosis-Still an Unanswered Priority?
    Sobel J
    Sex Transm Dis; 2024 Jun; 51(6):441-443. PubMed ID: 38733974
    [No Abstract]   [Full Text] [Related]  

  • 2. Probiotic strategies for the treatment and prevention of bacterial vaginosis.
    MacPhee RA; Hummelen R; Bisanz JE; Miller WL; Reid G
    Expert Opin Pharmacother; 2010 Dec; 11(18):2985-95. PubMed ID: 21080853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The probiotic Lactobacillus acidophilus--an alternative treatment of bacterial vaginosis].
    Andreeva P; Dimitrov A
    Akush Ginekol (Sofiia); 2002; 41(6):29-31. PubMed ID: 12577502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saccharomyces cerevisiae-based probiotic as novel anti-microbial agent for therapy of bacterial vaginosis.
    Sabbatini S; Monari C; Ballet N; Mosci P; Decherf AC; PĂ©lerin F; Perito S; Scarpelli P; Vecchiarelli A
    Virulence; 2018 Dec; 9(1):954-966. PubMed ID: 29683763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase 2a study assessing colonization efficiency, safety, and acceptability of Lactobacillus crispatus CTV-05 in women with bacterial vaginosis.
    Hemmerling A; Harrison W; Schroeder A; Park J; Korn A; Shiboski S; Foster-Rosales A; Cohen CR
    Sex Transm Dis; 2010 Dec; 37(12):745-50. PubMed ID: 20644497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of lactic acid production by probiotic Lactobacillus species in vaginal health.
    Tachedjian G; Aldunate M; Bradshaw CS; Cone RA
    Res Microbiol; 2017; 168(9-10):782-792. PubMed ID: 28435139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study.
    Larsson PG; Stray-Pedersen B; Ryttig KR; Larsen S
    BMC Womens Health; 2008 Jan; 8():3. PubMed ID: 18197974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotics in the prevention of recurrences of bacterial vaginosis.
    Parma M; Stella Vanni V; Bertini M; Candiani M
    Altern Ther Health Med; 2014; 20 Suppl 1():52-7. PubMed ID: 24473986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs.
    van de Wijgert J; Verwijs MC
    BJOG; 2020 Jan; 127(2):287-299. PubMed ID: 31299136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics for preventing recurrent bacterial vaginosis.
    Webb L
    JAAPA; 2021 Feb; 34(2):19-22. PubMed ID: 33448711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial vaginosis: a review on clinical trials with probiotics.
    Mastromarino P; Vitali B; Mosca L
    New Microbiol; 2013 Jul; 36(3):229-38. PubMed ID: 23912864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Not Available].
    Steurer J
    Praxis (Bern 1994); 2020 Sep; 109(12):1003-1004. PubMed ID: 32933399
    [No Abstract]   [Full Text] [Related]  

  • 13. Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV.
    Hummelen R; Changalucha J; Butamanya NL; Cook A; Habbema JD; Reid G
    Int J Gynaecol Obstet; 2010 Dec; 111(3):245-8. PubMed ID: 20801446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.
    Marcotte H; Larsson PG; Andersen KK; Zuo F; Mikkelsen LS; Brandsborg E; Gray G; Laher F; Otwombe K
    BMC Infect Dis; 2019 Sep; 19(1):824. PubMed ID: 31533663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics for the treatment of bacterial vaginosis.
    Senok AC; Verstraelen H; Temmerman M; Botta GA
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006289. PubMed ID: 19821358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Physiological recovery of vaginal flora, prophylaxis and treatment of bacterial vaginosis].
    Akush Ginekol (Sofiia); 2008; 47(5):47-8. PubMed ID: 19227776
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lactobor Intim vaginal gel for the treatment and prevention of bacterial vaginosis].
    Malinova M
    Akush Ginekol (Sofiia); 2009; 48 Suppl 2():32-3. PubMed ID: 20380096
    [No Abstract]   [Full Text] [Related]  

  • 18. Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis.
    Recine N; Palma E; Domenici L; Giorgini M; Imperiale L; Sassu C; Musella A; Marchetti C; Muzii L; Benedetti Panici P
    Arch Gynecol Obstet; 2016 Jan; 293(1):101-107. PubMed ID: 26142892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal retention of locally administered clindamycin.
    Eriksson K; Larsson PG; Nilsson M; Forsum U
    APMIS; 2011 Jun; 119(6):373-6. PubMed ID: 21569095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis.
    Anukam KC; Osazuwa E; Osemene GI; Ehigiagbe F; Bruce AW; Reid G
    Microbes Infect; 2006 Oct; 8(12-13):2772-6. PubMed ID: 17045832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.